Schering Ag Articles
Bayer/Schering AG deal satisfied HSR Act
1 May 2006
Schering AG names Detlef Olufs to supervisory board
24 April 2006
16% 1st-qtr 2006 sales rise for Schering AG
24 April 2006
Stock Commentary - Europe - week to April 10, 2006
17 April 2006
LIFT study: good results for Schering's Betaferon
10 April 2006
Stock Commentary - Europe - week to April 3, 2006
10 April 2006
Impact of Bayer's buy of Schering AG
3 April 2006
Stock Commentary - Europe - week to March 27, 2006
3 April 2006
Bayer "will not break up Schering AG"
3 April 2006
Schering AG's Yaz gets FDA go ahead
27 March 2006
Lamberti steps down from Schering AG supervisory board
27 March 2006
Stock Commentary - Europe - week to Mar 20, 2006
27 March 2006
Berlex in deal with GeneGo
20 March 2006
Dieter Hinzen nominated to Schering AG supervisory board
20 March 2006
Stock Commentary - Europe - week to Mar 13, 2006
20 March 2006
Stock Commentary - Europe - week to Mar 6, 2006
13 March 2006
Schering AG sees 2005 net leap 23%
27 February 2006
Titan/Schering's Spheramine NDA granted US fast track status
27 February 2006
Stock Commentary - Europe - week to Feb 20, 2006
27 February 2006
Peter Zundorf to head up Schering AG's oncology business
6 February 2006
US FDA gives tentative OK for Schering's Yaz in PMDD
30 January 2006
Ph IIa trial of EPIX' EP-2104R close to full enrollment
9 January 2006
Schering AG's osteoperosis patch gets US go ahead
9 January 2006
Schering AG divest interst in ALK-Scherax
19 December 2005
Stock Commentary - Europe - week to Dec 12
19 December 2005
Schering AG reveals new business model for its Jenapharm subsidiary
19 December 2005
FDA extends review of Schering's Yaz NDA
19 December 2005
David Guy joins Favrille as chief commercial officer
12 December 2005
Schering AG continues its strategic review
12 December 2005
Schering AG initiates Phase II cancer trials
12 December 2005
Schering and Philip to collaborate on optical imaging
5 December 2005
Stock Commentary - Europe - week to Nov 28
5 December 2005
Schering and SMS enter CT scan accord
5 December 2005
Stock Commentary - Europe - week to Sept 12
19 September 2005
Stock Commentary - Europe - week to Aug 15
22 August 2005
Schering AG gets approval in the Netherlands for Yasminelle
22 August 2005
Berlex awarded HPG Magnevist contract
15 August 2005
Stock Commentary - Europe
1 August 2005
Schering AG 1st-half profits leap 23%
1 August 2005
Schering AG completes enrollment in Betaferon trial
25 July 2005
FDA accepts EPIX' Vasovist submission
11 July 2005
Stock Commentary - Europe
4 July 2005
Positive CHMP opinion for Schering AG's Vasovist
4 July 2005
Stock Commentary - European
27 June 2005
Schering AG completes BENEFIT Ph III study in MS
27 June 2005
Positive Ph II data for Schering AG's Zevalin
20 June 2005
Schering AG opens Asia-Pacific HQ in Singapore
20 June 2005
Positive Ph II data for Schering AG's Zevalin
20 June 2005
Valentis expands licensing deal with Schering AG
13 June 2005
Schering AG swaps Medac holdings
13 June 2005
Stock Commentary - Europe
30 May 2005
Stock Commentary - Europe
23 May 2005
Stock Commentary - Europe
16 May 2005
Berlex, Premier in new MRI contrast deal
9 May 2005
Stock Commentary - Europe
28 April 2005
Schering report strong results for MS drug Betaferon
25 April 2005
Sawai Pharma takes over Nihon Schering's Mobara plant
25 April 2005
EPIX begins study of MRI clot diagnostic
18 April 2005
Stock Commentary - Europe
11 April 2005
Stock Commentary - Europe
4 April 2005
Barr confirms filing in USA for Yasmin
4 April 2005
Stock Commentary - Europe
28 March 2005
UPDATE: Schering AG delays cancer drug PTK/ZK
28 March 2005
Positive Ph III data for cancer drug PTK/ZK
28 March 2005
Schering AG's Yasmin under pressure in USA
28 March 2005
Stock Commentary - Europe
14 March 2005
UPDATE: Biogen and Elan pull MS drug Tysabri from the market on two cases of CNS disorder
7 March 2005
Cenix signs research deal with Schering AG
7 March 2005
Stock Commentary - Europe
28 February 2005
Schering AG to sell French plant
28 February 2005
New EU states: major potential for pharma/ biotech but PIs still a challenge, says study
28 February 2005
Stock Commentary - Europe
21 February 2005
German pharma eyes Pfizer cost-cutting
21 February 2005
Microdosing trial produces good result
21 February 2005
Stock Commentary - Europe
14 February 2005
Intendis enters market as new dermatology specialist
14 February 2005
Schering AG sells Pfizer its ADP CV program
7 February 2005
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
